1. Home
  2. BCTX vs DLPN Comparison

BCTX vs DLPN Comparison

Compare BCTX & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCTX
  • DLPN
  • Stock Information
  • Founded
  • BCTX 2014
  • DLPN 1996
  • Country
  • BCTX Canada
  • DLPN United States
  • Employees
  • BCTX N/A
  • DLPN N/A
  • Industry
  • BCTX Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • BCTX Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • BCTX Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • BCTX 18.5M
  • DLPN 21.8M
  • IPO Year
  • BCTX N/A
  • DLPN N/A
  • Fundamental
  • Price
  • BCTX $8.20
  • DLPN $1.61
  • Analyst Decision
  • BCTX Strong Buy
  • DLPN Strong Buy
  • Analyst Count
  • BCTX 1
  • DLPN 1
  • Target Price
  • BCTX $40.00
  • DLPN $5.00
  • AVG Volume (30 Days)
  • BCTX 45.4K
  • DLPN 37.2K
  • Earning Date
  • BCTX 12-15-2025
  • DLPN 11-12-2025
  • Dividend Yield
  • BCTX N/A
  • DLPN N/A
  • EPS Growth
  • BCTX N/A
  • DLPN N/A
  • EPS
  • BCTX N/A
  • DLPN N/A
  • Revenue
  • BCTX N/A
  • DLPN $53,371,115.00
  • Revenue This Year
  • BCTX N/A
  • DLPN $9.05
  • Revenue Next Year
  • BCTX N/A
  • DLPN $15.42
  • P/E Ratio
  • BCTX N/A
  • DLPN N/A
  • Revenue Growth
  • BCTX N/A
  • DLPN 3.86
  • 52 Week Low
  • BCTX $6.00
  • DLPN $0.75
  • 52 Week High
  • BCTX $190.50
  • DLPN $1.88
  • Technical
  • Relative Strength Index (RSI)
  • BCTX 36.92
  • DLPN 54.62
  • Support Level
  • BCTX $6.93
  • DLPN $1.50
  • Resistance Level
  • BCTX $11.54
  • DLPN $1.84
  • Average True Range (ATR)
  • BCTX 0.78
  • DLPN 0.14
  • MACD
  • BCTX -0.39
  • DLPN -0.01
  • Stochastic Oscillator
  • BCTX 22.77
  • DLPN 61.09

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: